Harel Insurance Investments & Financial Services Ltd. - INTEC PHARMA LTD JERUSALEM ownership

Quarter-by-quarter ownership
Harel Insurance Investments & Financial Services Ltd. ownership history of INTEC PHARMA LTD JERUSALEM
ValueSharesWeighting
Q2 2021$0
-100.0%
11
-100.0%
0.00%
-100.0%
Q3 2020$99,000
-4.8%
392,492
+6.9%
0.00%
-25.0%
Q2 2020$104,000367,325
+61948.1%
0.00%
Q1 2020$0
-100.0%
592
-99.8%
0.00%
-100.0%
Q4 2019$184,000
-52.5%
367,326
-30.8%
0.01%
-68.0%
Q3 2019$387,000
-85.7%
530,573
-15.1%
0.02%
-82.8%
Q2 2019$2,711,000
+752.5%
624,809
+1335.5%
0.14%
+663.2%
Q1 2019$318,000
-93.4%
43,526
-93.2%
0.02%
-93.6%
Q4 2018$4,810,000
+29.2%
637,935
-3.2%
0.30%
+60.3%
Q3 2018$3,722,000
+2719.7%
658,835
+2096.1%
0.18%
+2528.6%
Q2 2018$132,00030,0000.01%
Other shareholders
INTEC PHARMA LTD JERUSALEM shareholders Q3 2023
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 809,804$4,140,0000.60%
SABBY MANAGEMENT, LLC 514,878$2,652,0000.14%
Migdal Insurance & Financial Holdings Ltd. 497,200$2,542,0000.06%
Renaissance Technologies 12,944$66,0000.00%
DEUTSCHE BANK AG\ 12,724$65,0000.00%
View complete list of INTEC PHARMA LTD JERUSALEM shareholders